Jane Street’s NeuroOne Medical Technologies NMTC Stock Holding History

Jane Street’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,385	Closed	-$47.2K	–	12530
2025 Q4	$47.2K	Sell	10,385 -7,665	-42%	-$34.9K	﹤0.01%	10523
2025 Q3	$96.2K	Buy	+18,050	New	+$88.4K	﹤0.01%	10151
2025 Q1	–	Sell	-6,659	Closed	-$33K	–	10229
2024 Q4	$33K	Buy	+6,659	New	+$33.2K	﹤0.01%	9063
2023 Q1	–	Sell	-3,526	Closed	-$25.4K	–	9628
2022 Q4	$25.4K	Buy	3,526 +146	+4%	+$1.31K	﹤0.01%	8546
2022 Q3	$34K	Buy	+3,380	New	+$32.1K	﹤0.01%	9059

Other funds holding NMTC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Jane Street's NMTC Position: Q1 2026 in Review

Jane Street sold out of NeuroOne Medical Technologies (NMTC) in Q1 2026, closing a stake of 10,385 shares — an estimated $47.2K sold.

Jane Street first reported a position in NMTC in Q3 2022 and held it in 5 quarters. The position peaked at $96.2K in Q3 2025. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

Jane Street reported no remaining NeuroOne Medical Technologies position as of Q1 2026 after selling out during the quarter.
Jane Street sold 10,385 NeuroOne Medical Technologies shares in Q1 2026, an estimated $47.2K.
Jane Street first reported a position in NeuroOne Medical Technologies in Q3 2022 and held it in 5 quarters.
Jane Street's NeuroOne Medical Technologies position peaked at $96.2K in Q3 2025.
32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.